Thomas Stankovich
Director of Finance/CFO bei RESHAPE LIFESCIENCES INC.
Vermögen: 4 284 $ am 31.03.2024
Profil
Thomas Stankovich is currently working as the Chief Financial Officer & Senior Vice President at ReShape Weightloss, Inc. since 2019.
He is also currently serving as the Chief Financial Officer, Secretary & Senior VP at ReShape Lifesciences, Inc. since 2021.
Previously, Mr. Stankovich held the position of Chief Financial Officer & Senior Vice President at Ribapharm, Inc. from 2001 to 2003.
He also worked as the Chief Financial Officer, Treasurer & EVP at Cobalis Corp.
from 2005 to 2006, and as the Chief Financial Officer, Secretary & VP at Response Genetics, Inc. from 2006 to 2010.
Additionally, he served as the Chief Financial Officer & Senior Vice President at MP Biomedicals LLC from 2003 to 2005, and as the Chief Financial Officer & Vice President at ICN International AG from 2000 to 2001.
Mr. Stankovich's education background includes an undergraduate degree from California State University-Northridge.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2023 | 23 282 ( 0,10% ) | 4 284 $ | 31.03.2024 |
Aktive Positionen von Thomas Stankovich
| Unternehmen | Position | Beginn |
|---|---|---|
| RESHAPE LIFESCIENCES INC. | Director of Finance/CFO | 15.06.2021 |
ReShape Weightloss, Inc.
 ReShape Weightloss, Inc. Medical SpecialtiesHealth Technology ReShape Weightloss, Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShape vBloc. The company was founded in December 2002 and is headquartered in San Clemente, CA. | Director of Finance/CFO | 30.10.2019 |
Ehemalige bekannte Positionen von Thomas Stankovich
| Unternehmen | Position | Ende |
|---|---|---|
| RESPONSE GENETICS, INC | Director of Finance/CFO | 02.04.2010 |
Cobalis Corp.
 Cobalis Corp. Pharmaceuticals: OtherHealth Technology Cobalis Corp. is a pharmaceutical and nutraceutical company. Its flagship product, PreHistin designs to prevent the primary causes of airborne allergies. Cobalis specializes in the development of anti allergy medications. The company was founded in 1997 and is headquartered in Irvine, CA. | Director of Finance/CFO | 18.12.2006 |
MP Biomedicals LLC
 MP Biomedicals LLC BiotechnologyHealth Technology MP Biomedicals LLC manufactures and sells biotechnology research products. Its products include adsorbents, antibodies and immunoreagents, apoptosis, biochemicals and reagents, culture media and reagents, kits and assays, lab detergents and sanitizers, labware and instruments, proteins, enzymes, and peptides, radiochemicals, rare and fine chemicals, and research diets. The company was founded by Milan Paninc in 1959 and is headquartered in Santa Ana, CA. | Director of Finance/CFO | 01.12.2005 |
Ribapharm, Inc.
 Ribapharm, Inc. Pharmaceuticals: MajorHealth Technology Ribapharm, Inc. discovers, develops and markets antiviral and anticancer pharmaceuticals. The company is located in Costa Mesa, CA | Director of Finance/CFO | 01.01.2003 |
| ICN International AG | Director of Finance/CFO | 01.01.2001 |
Ausbildung von Thomas Stankovich
| California State University-Northridge | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RESPONSE GENETICS, INC | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Ribapharm, Inc.
Ribapharm, Inc. Pharmaceuticals: MajorHealth Technology Ribapharm, Inc. discovers, develops and markets antiviral and anticancer pharmaceuticals. The company is located in Costa Mesa, CA | Health Technology |
Cobalis Corp.
Cobalis Corp. Pharmaceuticals: OtherHealth Technology Cobalis Corp. is a pharmaceutical and nutraceutical company. Its flagship product, PreHistin designs to prevent the primary causes of airborne allergies. Cobalis specializes in the development of anti allergy medications. The company was founded in 1997 and is headquartered in Irvine, CA. | Health Technology |
Obalon Therapeutics, Inc.
 Obalon Therapeutics, Inc. Medical SpecialtiesHealth Technology Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated. The company was founded on January 2, 2008 and is headquartered in Carlsbad, CA. | Health Technology |
MP Biomedicals LLC
MP Biomedicals LLC BiotechnologyHealth Technology MP Biomedicals LLC manufactures and sells biotechnology research products. Its products include adsorbents, antibodies and immunoreagents, apoptosis, biochemicals and reagents, culture media and reagents, kits and assays, lab detergents and sanitizers, labware and instruments, proteins, enzymes, and peptides, radiochemicals, rare and fine chemicals, and research diets. The company was founded by Milan Paninc in 1959 and is headquartered in Santa Ana, CA. | Health Technology |
| ICN International AG | |
| ICN/DN Europe | |
ReShape Weightloss, Inc.
ReShape Weightloss, Inc. Medical SpecialtiesHealth Technology ReShape Weightloss, Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShape vBloc. The company was founded in December 2002 and is headquartered in San Clemente, CA. | Health Technology |
| ReShape Lifesciences, Inc. |
